Malley Thomas

CIK 00014033227 companiesDENVER, CO

SEC Profile

Transactions

Companies

Filings

CIK

0001403322

Recent Transactions

50 trades

Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-08-14−33,237→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-08-14−18,760→ 0 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Shares
2025-08-14$33.09/sh−78,233→ 12,546 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Shares
2025-08-14$14.33/sh+33,237→ 64,543 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Shares
2025-08-14$15.19/sh+26,236→ 90,779 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Shares
2025-08-14$15.47/sh+18,760→ 31,306 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-08-14−26,236→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Shares
2025-08-13$10.36/sh+20,129→ 32,675 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-08-13−20,129→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Shares
2025-08-13$9.88/sh+30,000→ 62,675 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Shares
2025-08-13$33.32/sh−50,129→ 12,546 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-08-13−30,000→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-08-12−27,448→ 0 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Shares
2025-08-12$32.40/sh−49,407→ 12,546 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Shares
2025-08-12$3.80/sh+27,448→ 61,953 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Shares
2025-08-12$1.86/sh+21,959→ 34,505 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-08-12−21,959→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Shares
2025-06-05+3,173→ 12,546 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2025-06-05−3,173→ 0 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2025-06-05+28,500→ 28,500 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-06-03+16,798→ 16,798 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2025-06-03+2,799→ 2,799 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2024-06-06−4,373→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Common Shares
2024-06-06+4,373→ 9,373 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2024-06-05+3,173→ 3,173 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2024-06-05+19,040→ 19,040 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2024-06-05+26,000→ 26,000 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2023-06-29−5,000→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Common Shares
2023-06-29+5,000→ 5,000 total
Purchase
Kura Oncology, Inc.$KURA
Common stock
2023-06-16$11.50/sh+50,000→ 139,557 total
Award
BeOne Medicines Ltd.$ONC
Share Option (Right to Buy)
2023-06-15+26,975→ 26,975 total
Award
BeOne Medicines Ltd.$ONC
Ordinary Shares
2023-06-15+12,922→ 46,696 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2023-06-06+4,373→ 4,373 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2023-06-06+26,236→ 26,236 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2023-05-31+26,000→ 26,000 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2022-06-29+30,000→ 30,000 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2022-06-29+5,000→ 5,000 total
Award
BeOne Medicines Ltd.$ONC
Share Option (Right to Buy)
2022-06-22+34,645→ 34,645 total
Award
BeOne Medicines Ltd.$ONC
Ordinary Shares
2022-06-22+16,692→ 33,774 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2022-06-21+23,000→ 23,000 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2021-06-29+33,237→ 33,237 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2021-06-22+23,000→ 23,000 total
Award
BeOne Medicines Ltd.$ONC
Ordinary Shares
2021-06-16+7,800→ 17,082 total
Award
BeOne Medicines Ltd.$ONC
Share Option (Right to Buy)
2021-06-16+17,498→ 17,498 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2020-06-30+18,760→ 18,760 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2020-06-24+23,000→ 23,000 total
Award
BeOne Medicines Ltd.$ONC
Share Option (Right to Buy)
2020-06-17+45,383→ 45,383 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2019-06-25+13,000→ 13,000 total
Award
BeOne Medicines Ltd.$ONC
Share Option (Right to Buy)
2019-06-05+64,610→ 64,610 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2019-05-29+18,760→ 18,760 total

Companies

Recent Filings

Address

295 CLAYTON

DENVER, CO, 80206

View on SEC.gov